HONG KONG, March 23, 2025 /PRNewswire/ — HashKey Chain announced that the tokenized USD Money Market Fund, “CPIC Estable MMF”, initiated and managed by CPIC Investment Management (H.K.) Co, Ltd, was successfully deployed on HashKey Chain, with subscription volume reaching USD 100 million…
Category: Uncategorized
SINGAPORE, March 24, 2025 /PRNewswire/ — Impact fund manager Abler Nordic has partnered with Temasek Foundation, a Singapore-based philanthropic organisation that drives impact programmes in Asia, together with sustainable palm oil producer Musim Mas, and Livelihoods Funds to launch the…
SINGAPOUR, 24 mars 2025 /PRNewswire/ — Le gestionnaire de fonds d’impact Abler Nordic s’est associé à la Fondation Temasek, une organisation philanthropique basée à Singapour qui dirige des programmes d’impact en Asie, ainsi qu’au producteur d’huile de palme durable Musim Mas et à…
Cerca de 40,000 clientes reciben descuentos en su factura mensual por estar inscritos en programas de benficios. UNIONDALE, Nueva York, 23 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/ — Aunque la temporada de calefacción está llegando a su fin y los programas de asistencia del Estado…
– Xinhua Silk Road: Foro paralelo sobre finanzas inclusivas y enfoques para el desarrollo de la nueva industrialización energética celebrado en Beijing BEIJING, 24 de marzo, 2025 /PRNewswire/ — El foro paralelo sobre finanzas inclusivas y enfoques para el desarrollo de la nueva…
Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 23, 2025 /PRNewswire/ — As the demand for surgical precision and faster patient recovery continues to grow, smart healthcare has achieved another major breakthrough. Since 2006, Chang…
SHANGHAI, March 23, 2025 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received 2025 CDMO Leadership Awards in the “Biologics – Global” category. It has also been…
SUZHOU, China, March 23, 2025 /PRNewswire/ — CStone Pharmaceuticals (“CStone”, HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the European Medicines Agency (EMA) for…
SHANGHAI, March 24, 2025 /PRNewswire/ — 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Exhibition & Convention Center on June 25-27. As a leading coil winding and electrical manufacturing event in Asia, CWIEME Shanghai serves as…
SAN FRANCISCO and SUZHOU, China, March 23, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic,…